Raymond James & Associates’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $13.8K | Buy |
|
|||||
|
2023
Q4 | $10K | Sell |
|
|||||
|
2023
Q3 | $281K | Buy |
|
|||||
|
2023
Q2 | $302K | Sell |
|
|||||
|
2023
Q1 | $548K | Buy |
|
|||||
|
2022
Q4 | $596K | Sell |
|
|||||
|
2022
Q3 | $697K | Buy |
|
|||||
|
2022
Q2 | $508K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $202K | Buy |
|
|||||
|
2019
Q4 | $349K | Buy |
|
|||||
|
2019
Q3 | $286K | Sell |
|
|||||
|
2019
Q2 | $411K | Sell |
|
|||||
|
2019
Q1 | $1.03M | Buy |
|
|||||
|
2018
Q4 | $893K | Sell |
|
|||||
|
2018
Q3 | $1.08M | Sell |
|
|||||
|
2018
Q2 | $970K | Sell |
|
|||||
|
2018
Q1 | $1.09M | Buy |
|
|||||
|
2017
Q4 | $458K | Buy |
|
|||||
|
2017
Q3 | $391K | Hold |
|
|||||
|
2017
Q2 | $330K | Buy |
|
|||||
|
2017
Q1 | $417K | Buy |
|
|||||
|
2016
Q4 | $256K | Buy |
|